Back

Traditional heart failure drug use in cardiac amyloid patients: insights from an international survey

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: Chronic heart failure - pathophysiology and mechanisms 2 Heart Failure with Preserved Ejection Fraction (HFpEF) HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Professor Nathan Mewton

Civils Hospices of Lyon, Lyon (France)

6 More presentations in this session

Presentation thumbnail
Echocardiographic characteristics of patients with CpcPH, and IpcPH in HFpEF, insight of PHHF study
Doctor E. Berthelot (Le Kremlin-Bicetre, FR)
Abstract Slides Video
Presentation thumbnail
Rationale and design of the PACIFIC-PRESERVED (PhenomApping, ClassIFication, and Innovation for Cardiac dysfunction in patients with heart failure and PRESERVED left ventricular EF) study
Professor J. Hulot (Paris, FR)
Abstract Slides Video
Presentation thumbnail
Effects of SGLT2i on CGA and biomarkers of oxidative stress and platelet activation in elderly diabetic patients with HFpEF.
Associate Professor A. Sciacqua (Catanzaro, IT) Doctor G. Armentaro (Catanzaro, IT)
Abstract Slides Video
Presentation thumbnail
Cardiac amyloidosis awareness comparison between HF-cardiologists, non-HF-cardiologists and other specialties around the world: insights from international survey
Miss F. Guidetti (Bern, CH)
Abstract Slides Video
Presentation thumbnail
Echocardiographic iron responders - assessing which HFrEF patients with iron deficiency benefit the most from iron therapy
Doctor C. Bakogiannis (Thessaloniki, GR)
Abstract Slides Video

Access the full session

Session thumbnail
Chronic heart failure - pathophysiology and mechanisms 2

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
Cardiac amyloidosis awareness among physicians around the world: insights from an international survey
thumbnail
Congress Presentation
Cardiac amyloidosis awareness comparison between HF-cardiologists, non-HF-cardiologists and other specialties around the world: insights from international survey
thumbnail
Congress Presentation
Accesses to anti-amyloid disease-modifying therapy impact awareness about cardiac amyloidosis and clinical practice: insights from an international survey

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources